JOHNSON B KRISTINE 4

What Happened
Kristine B. Johnson, a director of ClearPoint Neuro, was granted 12,820 restricted stock units (RSUs) on May 21, 2026. The grant is reported as a derivative award (code A) with an acquisition price of $0.00, so there was no cash paid by the insider. Each RSU represents a contingent right to one share of CLPT common stock upon vesting.

Key Details

• Transaction date: 2026-05-21; filing date: 2026-05-26 (appears later than the standard 2-business-day Form 4 deadline).
• Award: 12,820 restricted stock units @ $0.00 (derivative award).
• Shares owned after transaction: not disclosed in this filing.
• Footnotes: (1) Each RSU converts to one share of CLPT common stock if and when vested. (2) RSUs vest on the earlier of the first anniversary of the grant date or the day immediately before the Company’s 2027 annual meeting of stockholders.
• Transaction code: A = Award/Grant.

Context
RSU grants to directors are common as compensation and do not represent an open-market purchase or sale. Because these are time- or event-contingent awards (not immediate share issuance), they do not necessarily indicate immediate bullish or bearish insider sentiment. The apparent late filing may be of interest to investors tracking real-time insider activity.